Work

Abstract 2495: STING agonists formulated into cancer vaccines (STINGVAX) can cure established tumor resistant to immune checkpoint blockade by activating NK cells

Year: 2015

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2015-2495

Authors: Young Kim, Drew Pardoll, Juan Fu, Tom Dubensky

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Aduro BioTech (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2562495197

Cites:

Cited by: 3

Related to: 10